Simon Nebel has participated in the financing of several life science companies and M&A transactions for Aravis portfolio companies. He co-founded Aravis Energy I LP, the first Swiss Limited Partnership focused on renewable energy. He has served as a board member or observer in fourteen companies and is currently a board member of SynAffix (NL), MarinoMed (AT), Bird Rock Bio (La Jolla/USA), and BioSilu Healthcare (DE). Prior to Aravis, he was a group strategist at UBS in London, Basel, and Zurich, where he worked on business planning and modelling, including developing a Biotechnology Venture Capital proposal for UBS Capital. He holds a PhD in Biophysics from the Biocentre of the University of Basel (1996) and an MBA with distinction from the London Business School (2001).
BioTech, Energy
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...